Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Donner

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancer Biotherapy & Radiopharmaceuticals|March 26, 2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without <sup>223</sup>RaOrazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
Plos One|March 14, 2024
Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research studyMaria Chiara Malaguti, Lorenzo Gios, Bruno Giometto, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2015
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerClare Schilling, Sandro J Stoeckli, Stephan K Haerle, et al.
Clinical Nuclear Medicine|April 19, 2016
Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node TrialGirolamo Tartaglione, Sandro J Stoeckli, Remco de Bree, et al.
Head & Neck|February 1, 2012
Implications of a positive sentinel node in oral squamous cell carcinomaBenjamin A S Gurney, Clare Schilling, Venkata Putcha, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer Biotherapy & Radiopharmaceuticals|March 26, 2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without <sup>223</sup>RaOrazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
Plos One|March 14, 2024
Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research studyMaria Chiara Malaguti, Lorenzo Gios, Bruno Giometto, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2015
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerClare Schilling, Sandro J Stoeckli, Stephan K Haerle, et al.
Clinical Nuclear Medicine|April 19, 2016
Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node TrialGirolamo Tartaglione, Sandro J Stoeckli, Remco de Bree, et al.
Head & Neck|February 1, 2012
Implications of a positive sentinel node in oral squamous cell carcinomaBenjamin A S Gurney, Clare Schilling, Venkata Putcha, et al.
Pageof 3